Abstracts Archive - Page 295 of 1683 - ATC Abstracts

2021 American Transplant Congress
Short Term Outcomes in Previously Covid Positive Living Kidney Donors and Their Recipients
R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel
Henry Ford Transplant Institute, Detroit, MI
*Purpose: Study short term outcomes of living kidney donors (LKD) who were previously infected with COVID 19, and in their recipients.*Methods: After a brief hiatus…
2021 American Transplant Congress
Influence of Vitamin D Status on the Prognosis of Covid 19 in Patients with Kidney Transplant
J. Ugalde-Altamirano, I. Revuelta, A. Carrillo, M. Xipell, F. Cofan, N. Esforzado, E. Montagud, G. Piñeiro, A. Molina, P. Ventura, D. Cucchiari, F. Oppenheimer, F. Diekmann, J. Campistol, B. Bayes, J. Torregrosa
Nephrology, Hospital Clinic de Barcelona, Barcelona, Spain
*Purpose: The protective role of Vitamin D as an immunomodulator has been demonstrated in different pathologies included the viral etiology. This effect has been described…
2021 American Transplant Congress
Textbook Outcome: A Novel Metric in Lung Transplantation Outcomes
A. M. Ganapathi¹, B. A. Whitson¹, N. A. Mokadam¹, B. C. Keller², A. Logan¹, G. Brock¹, K. Washburn¹, A. D. Schenk¹
¹Surgery, Ohio State University Wexner Medical Center, Columbus, OH, ²Medicine, Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Lung transplant programs are typically assessed based on 1-/3-year survival, however other factors such as quality of life, freedom from rejection and oxygen, etc.,…
2021 American Transplant Congress
Evaluation of Fungal Prophylaxis Post-Lung Transplantation
I. Shah¹, K. Mohrien¹, C. Rose², J. Au¹
¹Temple University Hospital, Philadelphia, PA, ²Temple School of Pharmacy, Philadelphia, PA
*Purpose: Fungal infections are responsible for approximately 15-35% of all infections in lung transplant recipients; 80% of which are due to aspergillus or candida. At…
2021 American Transplant Congress
Dynamic Reconstitution of Recipient Resident Memory T Cell Repertoire After Human Intestinal Transplantation
W. Jiao, M. Martinez, J. Zuber, A. Obradovic, R. Jones, E. Waffarn, Z. Wang, A. Gorur, K. Rogers, T. Kato, Y. Shen, J. Fu, M. Sykes
Columbia University, New York, NY
*Purpose: Our studies in intestinal transplant (ITx) recipients demonstrated that donor T cell blood macrochimerism(peak level ≥4%) is associated with slower graft T cell replacement…
2021 American Transplant Congress
Removal of Race Factor in Egfr Decreases Disparities in Preemptive Listing for Kidney Transplantation
Y. Al-Salmay, N. Jandovitz, M. Abate, A. Baez, E. Molmenti, A. Fahmy, N. Breslin, L. Teperman, V. Nair
Organ Transplantation, Northwell Health, Manhasset, NY
*Purpose: GFR < 20 is required for kidney transplant listing. The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD)…
2021 American Transplant Congress
Kidney Transplantation in Patients with Prior Coronavirus Disease 2019 (COVID-19)
A. Santeusanio, A. Bhansali, M. Rana, S. Lerner, D. Von Ahrens, O. Sulimani, S. Farouk, F. Tedla, R. Shapiro
Mount Sinai Hospital, New York, NY
*Purpose: We describe short-term outcomes as well as peri- and post-transplant complications in patients with prior coronavirus disease 2019 (COVID-19) who subsequently underwent kidney transplantation.*Methods:…
2021 American Transplant Congress
AM PAC Scores and Liver Transplant Resource Utilization
M. Pierpont¹, M. Gosselin², K. Robichaux³, A. Kumar¹, J. Buggs⁴, N. Kemmer⁵
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of Tampa, Tampa, FL, ³Honors College, University of South Florida, Tampa, FL, ⁴Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁵Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: Activity Measure for Post-Acute Care (AM-PAC) is a tool utilized to assess three functional domains: basic mobility, daily activities, and applied cognition. Previous studies…
2021 American Transplant Congress
Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Data from the US Scientific Registry of Transplant Recipients (SRTR)
W. Fitzsimmons¹, J. Erdman², J. Wolfram³, D. Nimke², R. Croy², X. Wang², T. Weaver⁴, D. Schladt⁴
¹University of Illinois at Chicago, College of Pharmacy, Vernon Hills, IL, ²Astellas Pharma, Inc, Northbrook, IL, ³Astellas Pharma Europe BV, Leiden, Netherlands, ⁴Chronic Disease Research Group, Minneapolis, MN
*Purpose: There is currently no FDA approved immunosuppressive regimen for lung transplant (Tx) recipients; however, patients routinely receive a calcineurin inhibitor-based regimen. The SRTR database…
2021 American Transplant Congress
Ex Situ Heart Perfusion and Standard of Care Cold Storage Differentially Affect the Ischemic Secretome of Donor Hearts in Perfusates but Not the Reperfusion Response in Recipient Plasma
E. Chichelnitskiy¹, B. Wiegmann², N. Ledwoch¹, F. Ius², F. Wandrer¹, J. Kühne¹, K. Beushausen¹, J. Keil¹, S. V. Rojas², W. Sommer², C. Kühn², I. Tudorache², M. Avsar², A. Haverich², G. Warnecke², C. S. Falk¹
¹MHH, Institute of Transplant Immunology, Hannover, Germany, ²MHH, Department for Cardiothoracic, Transplantation and Vascular Surgery, Hannover, Germany
*Purpose: Various allograft preservation procedures influence the donor organ status that may be reflected by the cytokine/chemokine microenvironment in heart transplant (HTx) recipients. In addition,…